Pending questions in venous ulcers management. Report from a Symposium of the World Union of Wound Healing Societies International Congress

  • Giorgio Guarnera | gguarnera@tiscali.it Department of Vascular Surgery, Aurelia Hospital, Rome, Italy.
  • Paolo Zamboni Vascular Diseases Center, University of Ferrara, Italy.
  • Olle Nelzen Vascular Surgery Departments of Research and Development and Vascular Surgery, Skaraborg Hospital Skövde, Sweden.
  • Ferdinando Mannello Section of Clinical Biochemistry and Molecular Genetics, Department of Biomolecular Sciences, University Carlo Bo, Urbino, Italy.
  • Anneke Andriessen Radboud UMC, Nijmegen & Andriessen Consultants, Malden, Netherlands.

Abstract

Venous ulcers represent the most frequent ulcers and have a high clinical and socioeconomic significance. Nevertheless, pending questions remain on epidemiology, genetic and biomolecular mechanisms, contraindications and risk factors of compression therapy, role of pharmacological therapy. Overall prevalence in the range of 1-2% and point prevalence of 0.08-0.6% can be reduced if risk factors are identified and treated early. In this context, analysis of factor XIII and hemocromatosis gene polymorphisms, with the C282Y and H63D variants, may be of great importance. Also MMP12 gene polymorphism and the imbalance between matrix metalloproteinases and their tissue inhibitors are able to impair wound healing via deleterious degradation process of extra-cellular matrix. From a therapeutic point of view, conflicting recommendations exist on relative contraindications, risks and adverse events of compression therapy. Some studies showed that the administration of pentoxyphilline, Micronized purified flavonoid fraction (MPFF) and sulodexide was effective in accelerating ulcer healing, but there is no data on the duration of treatment, recurrence rates and cost-effectiveness relationship.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-11-12
Info
Issue
Section
Brief Reports
Keywords:
Epidemiology, gene polymorphisms, biomarkers, compression therapy, pharmacological therapy.
Statistics
  • Abstract views: 125

  • PDF: 51
How to Cite
Guarnera, G., Zamboni, P., Nelzen, O., Mannello, F., & Andriessen, A. (2020). Pending questions in venous ulcers management. Report from a Symposium of the World Union of Wound Healing Societies International Congress. Veins and Lymphatics, 9(3). https://doi.org/10.4081/vl.2020.9206

Most read articles by the same author(s)